| Dr David G Benditt, MD | |
|
1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303-2735 | |
| (320) 252-5131 | |
| Not Available |
| Full Name | Dr David G Benditt |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 52 Years |
| Location | 1200 Sixth Ave N, St Cloud, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073559134 | NPI | - | NPPES |
| 0998245 | Medicaid | IA | |
| 25-00021 | Other | MN | MEDICA PRIMARY |
| HP28844 | Other | MN | HEALTHPARTNERS |
| 1008980 | Other | MN | PREFERRED ONE |
| 768020 | Other | MN | ARAZ |
| 0051561 | Medicaid | MT | |
| 100780 | Other | MN | UCARE |
| 608268800 | Medicaid | MN | |
| 25-24794 | Other | MN | MEDICA CHOICE |
| 2T128BE | Other | MN | BCBS |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| University Medical Center-mesabi/ Mesaba Clinics | Hibbing, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Express Care | 3375645179 | 1523 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
| Entity Name | University Of Minnesota Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477598118 PECOS PAC ID: 9830001189 Enrollment ID: O20031104000532 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
| Entity Name | Centracare Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043212665 PECOS PAC ID: 2466363395 Enrollment ID: O20031105000293 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
| Entity Name | Healtheast St Joseph's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134186273 PECOS PAC ID: 2365348869 Enrollment ID: O20031208000245 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
| Entity Name | Healtheast Care System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194787465 PECOS PAC ID: 7214833763 Enrollment ID: O20031208000483 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
| Entity Name | University Of Minnesota Health Clinics And Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053795187 PECOS PAC ID: 9133423304 Enrollment ID: O20160209000524 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David G Benditt, MD 1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303-2735 Ph: (320) 252-5131 | Dr David G Benditt, MD 1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303-2735 Ph: (320) 252-5131 |
News Archive
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.
When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University School of Medicine in St. Louis have created a potential new type of anticancer therapy with the potential to target a wide range of tumors. This work was reported in the Journal of Clinical Investigation.
16 kilograms of Kava was seized by the Northern Territory Police as they arrested a well respected 56-year-old Aboriginal elder in connection. He will appear in court this May. Police from Ramingining in Arnhem Land stopped a Toyota Landcruiser at Barge Landing Road on Good Friday. The haul included 16 kg of Kava and small amounts of Cannabis. A police spokewoman revealed on Monday, "The Kava had a street value of $16,000 and was headed for Milingimbi Island before it was intercepted by police."
EIN News, an online leader in industry news monitoring and press syndication, has today added a new publication to its portfolio of health-related international news sites for industry professionals and analysts: Mesothelioma News Today (http://mesothelioma.einnews.com).
› Verified 4 days ago
Viorel Gheorghe, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1900 Centra Care Circle, Centracare Clinic, St Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2146 | |
Alexander J Schad, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave No, Centra Care Clinic, St Cloud, MN 56303 Phone: 320-252-5731 | |
Wesley Leland Lindquist, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 6th Ave N, Centracare Clinic, St Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 | |
Christopher Bruce Miller, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 1406 Sixth Avenue North, St Cloud, MN 56303 Phone: 320-229-4901 Fax: 320-229-5160 | |
Dr. Jessie Lee Kerns Roske, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave N, Centracare Clinic, St Cloud, MN 56303 Phone: 320-251-2700 | |
Paul L Marek, MD, FHM Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth Ave N, St Cloud, MN 56303 Phone: 320-251-2700 Fax: 320-240-2118 |